Sign Up! | Tags | Domains | Statistics | Options | Advanced Search
|
Sign Up! | Tags | Domains | Statistics | Options | Advanced Search |
xconomy.com » Xconomy - Nov 19, 2008
Biotech, Cash, Life Sciences Luke Timmerman wrote: These are grim times for many industries, and the life sciences are no exception. Most of these enterprises depend on the ability to raise fresh investment capital on …
Also tagged: obesity, biotech, invitrogen, fda, san diego, byetta, down syndrome, cash, lehman brothers, la jolla pharmaceutical, life sciences, genzyme, cypress bioscience, hollis eden pharmaceuticals, amylin pharmaceuticals, acadia pharmaceuticals, arena pharmaceuticals, sequenom, genoptix, isis pharmaceuticals, vical, orexigen therapeutics, national blog main, alnylam pharmaceuticals, mipomersen, optimer pharmaceuticals, regulus therapeutics, exenatide, ligand pharmaceuticals, san diego blog main, zegerid, anadys pharmaceuticals, somaxon pharmaceuticals, neurocrine biosciences, ista pharmaceuticals, cytori therapeutics, halozyme therapeutics, kleanthis xanthopoulus, genoptix medical, cadence pharmaceuticals, santarus pharmaceuticals
xconomy.com » Xconomy Life Sciences Feed - Nov 18, 2008
Biotech, Cash, Life Sciences Luke Timmerman wrote: These are grim times for many industries, and the life sciences are no exception. Most of these enterprises depend on the ability to raise fresh investment capital on …
Also tagged: obesity, biotech, invitrogen, fda, san diego, byetta, down syndrome, cash, lehman brothers, la jolla pharmaceutical, life sciences, genzyme, cypress bioscience, hollis eden pharmaceuticals, amylin pharmaceuticals, acadia pharmaceuticals, arena pharmaceuticals, sequenom, genoptix, isis pharmaceuticals, vical, orexigen therapeutics, national blog main, alnylam pharmaceuticals, mipomersen, optimer pharmaceuticals, regulus therapeutics, exenatide, ligand pharmaceuticals, san diego blog main, zegerid, anadys pharmaceuticals, somaxon pharmaceuticals, neurocrine biosciences, ista pharmaceuticals, cytori therapeutics, halozyme therapeutics, kleanthis xanthopoulus, genoptix medical, cadence pharmaceuticals, santarus pharmaceuticals
 |
Illumina Shows its Stuff to Wall Street, Stock Still Slidesxconomy.com » Xconomy - Nov 8, 2008 Biotech, Genetics, Instruments Luke Timmerman wrote: San Diego’s Illumina has a pretty amazing story to tell about exponential growth. The maker of genetic analysis tools has beaten or matched Wall Street earnings … Also tagged: google, biotech, genetics, applied biosystems, multiple sclerosis, fda, san diego, amgen, merck, type 1 diabetes, harvard, instruments, sergey brin, roche, vioxx, etanercept, anne wojcicki, inflammatory bowel disease, life sciences, humira, 23andme, rheumatoid arthritis, abbott laboratories, enbrel, national blog main, george church, helicos biosciences, cowen and 38 co, san diego blog main, jay flatley, adalimumab, christian henry, tristan orpan, doug schenkel, peter gregersen |
|
Illumina Shows its Stuff to Wall Street, Stock Still Slidesxconomy.com » Xconomy Life Sciences Feed - Nov 7, 2008 Biotech, Genetics, Instruments Luke Timmerman wrote: San Diego’s Illumina has a pretty amazing story to tell about exponential growth. The maker of genetic analysis tools has beaten or matched Wall Street earnings … Also tagged: google, biotech, genetics, applied biosystems, multiple sclerosis, fda, san diego, amgen, merck, type 1 diabetes, harvard, instruments, sergey brin, roche, vioxx, etanercept, anne wojcicki, inflammatory bowel disease, life sciences, humira, 23andme, rheumatoid arthritis, abbott laboratories, enbrel, national blog main, george church, helicos biosciences, cowen and 38 co, san diego blog main, jay flatley, adalimumab, christian henry, tristan orpan, doug schenkel, peter gregersen |
 |
Illumina Rolls Out Genome Analysis Softwaresocaltech.com » socalTECH.com - Southern California High Tech News - Oct 20, 2008 San Diego-based Illumina announced a new software product today, GenomeStudio, which the firm says can be used to analyze data from genetic research efforts. According to Illumina, the firm's new software allows … |
xconomy.com » Xconomy Life Sciences Feed - Oct 9, 2008
Biotech, Instruments, Illumina Luke Timmerman wrote: San Diego-based Illumina (NASDAQ: ILMN), the maker of instruments for genetic analysis, said today it has sold four new Genome Analyzer machines to the Genome …
Also tagged: cancer, biotech, mit, san diego, stem cells, instruments, life sciences, whitehead institute for biomedical research, san diego briefs, robert weinberg, genome institute of singapore, genome analyzer
xconomy.com » Xconomy Life Sciences Feed - Oct 8, 2008
Biotech, Sequencing, Complete Genomics Luke Timmerman wrote: It’s getting cheaper by the day to sequence the entire string of 6 billion chemical units of DNA that make up an individual human being. Yesterday, Complete …
Also tagged: science, biotech, applied biosystems, san diego, nature, genentech, harvard medical school, national institutes of health, sequencing, life sciences, 454 life sciences, enterprise partners, ovp venture partners, seattle blog main, leroy hood, george church, helicos biosciences, chad waite, institute for systems biology, san diego blog main, highland capital management, complete genomics, bruce bigelow, prospect venture partners, clifford reid, drew senyei
xconomy.com » Xconomy - Oct 7, 2008
Biotech, Sequencing, Complete Genomics Luke Timmerman wrote: It’s getting cheaper by the day to sequence the entire string of 6 billion chemical units of DNA that make up an individual human being. Yesterday, Complete …
Also tagged: science, biotech, applied biosystems, san diego, nature, genentech, harvard medical school, national institutes of health, sequencing, life sciences, 454 life sciences, enterprise partners, ovp venture partners, seattle blog main, leroy hood, george church, helicos biosciences, chad waite, institute for systems biology, san diego blog main, highland capital management, complete genomics, bruce bigelow, prospect venture partners, clifford reid, drew senyei
xconomy.com » Xconomy Seattle - Oct 6, 2008
Biotech, Sequencing, Complete Genomics Luke Timmerman wrote: It’s getting cheaper by the day to sequence the entire string of 6 billion chemical units of DNA that make up an individual human being. Yesterday, Complete …
Also tagged: science, biotech, applied biosystems, san diego, nature, genentech, harvard medical school, national institutes of health, sequencing, life sciences, 454 life sciences, enterprise partners, ovp venture partners, seattle blog main, leroy hood, george church, helicos biosciences, chad waite, institute for systems biology, san diego blog main, highland capital management, complete genomics, bruce bigelow, prospect venture partners, clifford reid, drew senyei
fiercebiotech.com » Untitled News Source - Sep 9, 2008
How low can 23andMe go? Lower than $999, apparently. The Google-backed genetic screening company has slashed the price of its Personal Genome Service test, which analyzes patients for inherited traits and provides some …
Also tagged: genomics, anne wojcicki, 23andme, genetic test